Rasha Aboelhassan: Discussion of metastatic Colorectal Cancer during Egyptian Gastro-hepto Oncology summit
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“I’m so proud today with the discussion of metastatic Colorectal Cancer mCRC during Egyptian Gastro-hepto Oncology summit EGO with group of experts with Oncology and gastro-entrology backgrounds. The main highlights was that:
To get the best clinical benefit for treatment of mCRC, we need to start strong by prescribing targeted therapy + chemotherapy. I’m proud that Egyptian government now allows all Egyptian mCRC patients to have this benefit for free, even those who had no insurance. This allows not only the greatest benefit, but also the high quality of life, now those patients can live their life surving, working laughing and having their treatment.”
Source: Rasha Aboelhassan/LinkedIn.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023